Preclinical experiments and single-cell RNA sequencing (scRNA-seq) analysis of post-treatment thyroid tumor patients revealed that the combination of anti-PD-1 treatment and famitinib, which targets VEGF/PDGF signaling, effectively induces TLS in thyroid tumors (107). This evidence concerns the gene PDCD1 and thyroid tumor.